Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain

Recently, nanocarriers that transport bioactive substances to a target site in the body have attracted considerable attention and undergone rapid progression in terms of the state of the art. However, few nanocarriers can enter the brain via a systemic route through the blood-brain barrier (BBB) to...

Descripción completa

Detalles Bibliográficos
Autores principales: Anraku, Y., Kuwahara, H., Fukusato, Y., Mizoguchi, A., Ishii, T., Nitta, K., Matsumoto, Y., Toh, K., Miyata, K., Uchida, S., Nishina, K., Osada, K., Itaka, K., Nishiyama, N., Mizusawa, H., Yamasoba, T., Yokota, T., Kataoka, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645389/
https://www.ncbi.nlm.nih.gov/pubmed/29042554
http://dx.doi.org/10.1038/s41467-017-00952-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645389/
https://www.ncbi.nlm.nih.gov/pubmed/29042554
http://dx.doi.org/10.1038/s41467-017-00952-3

Ejemplares similares